CLU and hepatocellular carcinoma: Subsequently, we detected the alteration of STAT3 activation when upregulating HSF1 expression in HCC cells (HepG2) with APOJ knockdown in order to verify the role of APOJ in modulating the JAK-STAT3 signaling activity.